-
TLIS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Talis Biomedical (TLIS)
Company Profile
Quarter (USD) | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 60.63 mm | 60.63 mm | 60.63 mm | 60.63 mm | 60.63 mm | 60.63 mm |
Cash burn (monthly) | 3.75 mm | 3.34 mm | 3.19 mm | 4.59 mm | 3.78 mm | 3.35 mm |
Cash used (since last report) | 30.29 mm | 27.02 mm | 25.80 mm | 37.12 mm | 30.52 mm | 27.11 mm |
Cash remaining | 30.34 mm | 33.62 mm | 34.83 mm | 23.51 mm | 30.11 mm | 33.52 mm |
Runway (months of cash) | 8.1 | 10.1 | 10.9 | 5.1 | 8.0 | 10.0 |
13F holders | Current |
---|---|
Total holders | 18 |
Opened positions | 16 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 6.84 bn |
Total shares | 789.49 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Baker Bros. Advisors | 508.32 k | $4.40 bn |
DME Capital Management | 149.05 k | $1.29 bn |
BML Capital Management | 42.74 k | $370.23 mm |
Vanguard | 31.01 k | $268.63 mm |
Prelude Capital Management | 14.93 k | $129.30 mm |
Geode Capital Management | 14.02 k | $123.42 mm |
Renaissance Technologies | 12.30 k | $106.53 mm |
Susquehanna International | 11.61 k | $102.14 mm |
BLK BlackRock | 4.27 k | $36.99 mm |
Tower Research Capital | 877.00 | $7.60 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Sep 24 | Braden Michael Leonard | Common Stock | Buy | Acquire P | Yes | No | 1.484 | 25,000 | 37.10 k | 248,702 |
5 Sep 24 | Braden Michael Leonard | Common Stock | Buy | Acquire P | Yes | No | 1.4 | 5,100 | 7.14 k | 223,702 |
3 Sep 24 | Braden Michael Leonard | Common Stock | Buy | Acquire P | Yes | No | 4 | 500 | 2.00 k | 218,602 |
30 Aug 24 | Braden Michael Leonard | Common Stock | Buy | Acquire P | Yes | No | 4.25 | 151 | 641.75 | 218,602 |
28 Aug 24 | Braden Michael Leonard | Common Stock | Buy | Acquire P | Yes | No | 3.9627 | 1,215 | 4.81 k | 217,951 |
26 Aug 24 | Braden Michael Leonard | Common Stock | Buy | Acquire P | Yes | No | 3.8978 | 13,167 | 51.32 k | 216,736 |